Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Arachidonic Acid and Methylene Blue

Research Papers that Mention the Interaction

Treating cells with either methylene blue (20 μm) or the cyclo‐oxygenase inhibitor, flurbiprofen (10 μm), inhibited both resting and arachidonic acid (1 μm)‐induced production of 6‐keto‐PGF1α.
British journal of pharmacology  •  1989  |  View Paper
In an attempt to elucidate the mechanisms of these responses, we found that preincubation with methylene blue , an inhibitor of soluble guanylate cyclase activity, inhibited both Ach and AA induced relaxation.
The Canadian journal of cardiology  •  1986  |  View Paper
Basal, arachidonic acid (10(-5) M)-stimulated, and nitroprusside (5 X 10(-5) M)-stimulated guanylate cyclase activities were inhibited by methylene blue and the lipoxygenase inhibitors nordihydroguaiaretic acid and eicosatetraynoic acid.
Hypertension  •  1986  |  View Paper
Indomethacin partially inhibited endothelium-dependent relaxation and abolished cyclic AMP accumulation whereas methylene blue , a guanylate cyclase inhibitor, partially inhibited relaxation and abolished cyclic GMP accumulation in response to arachidonic acid.
The Journal of pharmacology and experimental therapeutics  •  1985  |  View Paper